The 42th scientific meeting of the Israeli Association for Bone Marrow Transplantation

israeli association

Thursday, October 15, 2020
Start time: 3pm (Jerusalem), 2pm (Paris), 8am (NYC), 8pm (Hong Kong)

Click to register for this event (October 15th)

Scientific program  

15:00-15:05 - Opening Remarks
Prof. Arnon Nagler, Chaim Sheba Medical Center, Tel Hashomer, Israel

15:05-16:00 - Gamma -Delta based immunotherapy for hematological malignancies
Prof. Dr. Jürgen Kuball, Director of the Bone Marrow Transplantation Program at the University Medical Center in Utrecht, The Netherlands

16:00-16:30 - Gamma-Delta CAR-T Cells Show CAR-Directed and Independent Activity Against Leukemia
Dr Michal J Besser, Ella Lemelbaum Institute for Immuno Oncology Sheba Medical Center, Tel Aviv, Israel

16:30-17:00 - Relapse of AML post Allo-an unmet need
Prof Tzila Zuckerman, Director of the Department of Hematology and Bone Marrow Transplantation at Rambam Health Care Campus, Haifa, Israel

17:10-17:40 - Role of MRD in Allo for AML
Prof Arnon Nagler, Chaim Sheba Medical Center, Tel Hashomer, Israel

17:40-18:00 - CAR-T cells for DLBCL in patients over vs under 70y
Prof Ron Ram, Director, The Bone Marrow Transplantation Unit; The Division of Hematology,Tel Aviv Sourasky Medical Center,Tel Aviv ,Israel

17:50-18:10 - Diarrheal Morbidity in Patients Undergoing Hematopoietic Cell Transplantation – The Diagnostic Yield of Stool Cultures. A Retrospective Cohort Study
Dr Tamar Berger, Rabin Medical Center, Petach –Tikva, Israel

18:10-18:30 - Transplantation in Fanconi Anemia
Dr Even-Or Ehud, Pediatric Bone Marrow Transplantation, Hadassah Medical Center, Jerusalem, Israel

18:30-19:00 - Summary, Q&A
Prof Nagler, Prof Zuckerman and Faculty

This event is supported by an unrestricted grant from Astellas

Click to register for this event (October 15th)

Kontakt telefon

033 297 160

Kontakt email